Lifecore Biomedical Inc (LFCR)
5.20
-0.07
(-1.33%)
USD |
NASDAQ |
Jun 14, 16:00
5.18
-0.02
(-0.38%)
After-Hours: 20:00
Lifecore Biomedical Accounts Receivable (Quarterly): 29.71M for May 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
May 31, 2023 | 29.02M |
February 28, 2023 | 32.37M |
November 30, 2022 | 35.69M |
August 31, 2022 | 40.93M |
May 31, 2022 | 38.31M |
February 28, 2022 | 49.56M |
November 30, 2021 | 65.28M |
August 31, 2021 | 61.96M |
May 31, 2021 | 41.43M |
February 28, 2021 | 69.58M |
November 30, 2020 | 66.54M |
August 31, 2020 | 65.03M |
May 31, 2020 | 76.21M |
February 29, 2020 | 69.76M |
November 30, 2019 | 69.96M |
August 31, 2019 | 61.40M |
May 31, 2019 | 69.56M |
February 28, 2019 | 60.39M |
November 30, 2018 | 53.42M |
August 31, 2018 | 48.66M |
May 31, 2018 | 53.88M |
February 28, 2018 | 50.44M |
November 30, 2017 | 56.36M |
August 31, 2017 | 47.85M |
May 31, 2017 | 45.90M |
Date | Value |
---|---|
February 28, 2017 | 45.92M |
November 30, 2016 | 50.01M |
August 31, 2016 | 44.15M |
May 31, 2016 | 46.41M |
February 29, 2016 | 42.92M |
November 30, 2015 | 50.28M |
August 31, 2015 | 44.52M |
May 31, 2015 | 46.48M |
February 28, 2015 | 45.31M |
November 30, 2014 | 52.30M |
August 31, 2014 | 43.80M |
May 31, 2014 | 44.72M |
February 28, 2014 | 41.23M |
November 30, 2013 | 41.88M |
August 31, 2013 | 33.18M |
May 31, 2013 | 36.74M |
February 28, 2013 | 37.58M |
November 30, 2012 | 40.91M |
August 31, 2012 | 30.56M |
May 31, 2012 | 32.27M |
February 29, 2012 | 23.74M |
November 30, 2011 | 29.37M |
August 31, 2011 | 20.77M |
May 31, 2011 | 22.11M |
February 28, 2011 | 19.48M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
29.02M
Minimum
May 2023
76.21M
Maximum
May 2020
54.56M
Average
61.68M
Median
Accounts Receivable (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 6.703M |
SELLAS Life Sciences Group Inc | -- |
ADMA Biologics Inc | 49.62M |
Relmada Therapeutics Inc | -- |
Jaguar Health Inc | 1.512M |